Description
This racemic isoserine analog of TRAP-6 (SFLLRN) has only 15-20% of the platelet aggregating activity of SFLLRN. In compensation iso-SFLLRN significantly resists degradation by aminopeptidase M and is much more stable in plasma and serum.




